A meta-analysis of neuropsychological change to clozapine, olanzapine, quetiapine, and risperidone in schizophrenia ND Woodward, SE Purdon, HY Meltzer, DH Zald International Journal of Neuropsychopharmacology 8 (3), 457-472, 2005 | 809 | 2005 |
Neuropsychological change in early phase schizophrenia during 12 months of treatment with olanzapine, risperidone, or haloperidol SE Purdon, BDW Jones, E Stip, A Labelle, D Addington, SR David, ... Archives of general psychiatry 57 (3), 249-258, 2000 | 649 | 2000 |
Neuropsychological change in patients with schizophrenia after treatment with quetiapine or haloperidol. SE Purdon, A Malla, A Labelle, W Lit Journal of psychiatry and neuroscience 26 (2), 137, 2001 | 294 | 2001 |
Compliance to health recommendations: A theoretical overview of message framing DK Wilson, SE Purdon, KA Wallston Health Education Research 3 (2), 161-171, 1988 | 223 | 1988 |
One-year double-blind study of the neurocognitive efficacy of olanzapine, risperidone, and haloperidol in schizophrenia RSE Keefe, CA Young, SL Rock, SE Purdon, JM Gold, A Breier, ... Schizophrenia research 81 (1), 1-15, 2006 | 220 | 2006 |
A meta-analysis of cognitive change with haloperidol in clinical trials of atypical antipsychotics: dose effects and comparison to practice effects ND Woodward, SE Purdon, HY Meltzer, DH Zald Schizophrenia Research 89 (1-3), 211-224, 2007 | 198 | 2007 |
Cognitive improvement in schizophrenia with novel antipsychotic medications SE Purdon Schizophrenia research 35, S51-S60, 1999 | 160 | 1999 |
Assessing and addressing cognitive impairment in bipolar disorder: the International Society for Bipolar Disorders Targeting Cognition Task Force recommendations for clinicians KW Miskowiak, KE Burdick, A Martinez‐Aran, CM Bonnin, CR Bowie, ... Bipolar disorders 20 (3), 184-194, 2018 | 153 | 2018 |
Screening for cognitive dysfunction in unipolar depression: validation and evaluation of objective and subjective tools CV Ott, AJ Bjertrup, JH Jensen, H Ullum, R Sjælland, SE Purdon, E Vieta, ... Journal of Affective Disorders 190, 607-615, 2016 | 130 | 2016 |
Measuring changes in functional status among patients with schizophrenia: the link with cognitive impairment LS Matza, R Buchanan, S Purdon, J Brewster-Jordan, Y Zhao, DA Revicki Schizophrenia bulletin 32 (4), 666-678, 2006 | 127 | 2006 |
Optimising screening for cognitive dysfunction in bipolar disorder: validation and evaluation of objective and subjective tools JH Jensen, MM Støttrup, E Nayberg, U Knorr, H Ullum, SE Purdon, ... Journal of Affective Disorders 187, 10-19, 2015 | 121 | 2015 |
Spanish version of the Screen for Cognitive Impairment in Psychiatry (SCIP-S): Psychometric properties of a brief scale for cognitive evaluation in schizophrenia O Pino, G Guilera, JE Rojo, J Gómez-Benito, M Bernardo, ... Schizophrenia Research 99 (1-3), 139-148, 2008 | 117 | 2008 |
The Screen for Cognitive Impairment in Psychiatry (SCIP): Instructions and three alternate forms SE Purdon PNL Inc, Edmonton, Alberta, 2005 | 117 | 2005 |
Antidepressant effects of repetitive transcranial magnetic stimulation in the elderly: correlation between effect size and coil-cortex distance SE Purdon Archives of General Psychiatry 59 (6), 573-575, 2002 | 114 | 2002 |
Abnormal prefrontal cortical activity and connectivity during response selection in first episode psychosis, chronic schizophrenia, and unaffected siblings of individuals with … ND Woodward, B Waldie, B Rogers, P Tibbo, P Seres, SE Purdon Schizophrenia Research 109 (1-3), 182-190, 2009 | 112 | 2009 |
Affective cognition in bipolar disorder: a systematic review by the ISBD targeting cognition task force KW Miskowiak, I Seeberg, HL Kjaerstad, KE Burdick, A Martinez‐Aran, ... Bipolar disorders 21 (8), 686-719, 2019 | 96 | 2019 |
Risperidone in the treatment of pervasive developmental disorder SE Purdon, W Lit, A Labelle, BDW Jones The Canadian Journal of Psychiatry 39 (7), 400-405, 1994 | 93 | 1994 |
Procedural learning in schizophrenia after 6 months of double-blind treatment with olanzapine, risperidone, and haloperidol SE Purdon, N Woodward, SR Lindborg, E Stip Psychopharmacology 169, 390-397, 2003 | 90 | 2003 |
Neurocognitive diagnosis and cut-off scores of the Screen for Cognitive Impairment in Psychiatry (SCIP-S) E Rojo, O Pino, G Guilera, J Gómez-Benito, SE Purdon, B Crespo-Facorro, ... Schizophrenia research 116 (2-3), 243-251, 2010 | 85 | 2010 |
Association of age, antipsychotic medication, and symptom severity in schizophrenia with proton magnetic resonance spectroscopy brain glutamate level: a mega-analysis of … K Merritt, PK McGuire, A Egerton, A Aleman, W Block, OJN Bloemen, ... JAMA psychiatry 78 (6), 667-681, 2021 | 84 | 2021 |